Waldemar P.
- Country
- Poland
- Department
- #5708:Dermatology
Research Overview
- An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis
- Long-Term Safety and Efficacy Assessment of Nemolizumab (CD14152) in Prurigo Nodularis Patients
- Long-Term Safety and Efficacy Assessment of Nemolizumab (CD14152) in Moderate-to-Severe Atopic Dermatitis Patients
Data & Insights
Has run more than one trial at 154 of 374 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in the treatment and research of chronic skin conditions, with particular emphasis on plaque psoriasis and atopic dermatitis. Their work focuses on evaluating innovative therapeutic approaches for patients with moderate to severe manifestations of these conditions.
- Moderate to Severe Plaque Psoriasis Management
- Atopic Dermatitis Treatment
- Long-term Disease Control
The investigator's expertise extends to both adult and adolescent patient populations, addressing chronic inflammatory skin disorders through systematic therapeutic evaluation.
Therapeutic Focus
Their research encompasses the evaluation of novel therapeutic agents, including targeted immunomodulators and biological treatments. The investigator's work is particularly centered on assessing long-term safety and efficacy profiles of emerging treatments.
- Novel Therapeutic Agents
- Long-term Safety Assessment
- Treatment Tolerability Studies
The research approach includes comprehensive evaluation of treatment responses in chronic dermatological conditions requiring sustained therapeutic intervention.
Clinical Expertise
The investigator demonstrates specialized knowledge in inflammatory skin diseases and their systemic management. Their clinical focus encompasses the evaluation of daily treatment regimens and their impact on patient outcomes.
- Inflammatory Skin Disease Management
- Chronic Disease Monitoring
- Treatment Response Assessment
Their work involves monitoring therapeutic efficacy and safety parameters in patients with chronic dermatological conditions requiring ongoing treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.